… as determined by FISH markers), particularly in patients with less … in cells from patients with
more advanced disease. These … epoetin alfa) is promising for the treatment of anemia of MDS …

… Anemia is commonly encountered in cancer patients receiving active chemotherapy. Due
to adverse events and presumed negative effects on disease-progression and survival, …

… of the disease or the treatment, in particular those patients … patients, four patients received
epoetin beta, and 1 patient … clinical practice of Spanish Oncology or Oncohematology services. …

… In the article are described in detail the methods of pathogenetic correction of anemic
syndrome using parenteral iron preparations, recombinant erythropoietin, indications for their …

… marrow involvement (oncohematologic conditions, dyserythropoietic or bone marrow failure
… patients with inadequate reticulocytosis, erythropoietin has been shown to improve anemia …

… anemia was greater in patients with more advanced disease. … EMA approved indications for
epoetin and darbepoetin alfa. … of biosimilar epoetin alfa in anaemic cancer patients, showed …

… (increased inflammatory markers: CRP >5.0 mg/L), anemia (<… and systemic effects of
erythropoietin and stem cells in uremia. … He also attended an updating course in Oncohematology …

… autoimmune conditions and cancer. Concerning the first … bleeding and, after excluding
onco-hematologic causes and … was treated with steroids and recombinant EPO epoetin alpha …

… erythropoietin (rHuEPO) treatment can increase hemoglobin levels, decreased transfusion
requirements, and improve quality of life in patients with cancer… in anaemia of chronic disease …

… incidence of the indications considered. However, feedbacks from clinicians in the field do
indicate that their ability to prescribe these three treatments within and across indications is …